Overview

Physician's Evaluation of Cyclosporine Ophthalmic Emulsion 0.05%

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The objective of this retrospective chart review is to evaluate the patient characteristics, treatment variations and efficacy of a second trial of Cyclosporine Ophthalmic Emulsion 0.05% therapy in chronic dry eye patients who were initially treated with Cyclosporine Ophthalmic Emulsion 0.05% but discontinued use after less than 12 weeks of treatment.
Details
Lead Sponsor:
Allergan
Treatments:
Cyclosporine
Cyclosporins